31 Racial Demographic Reporting in Clinical Trials Informing NCCN Kidney Cancer Guidelines
Suhail Sapkota, Niket Shah, Asish Nepal, Maha Bayya, Nadeen Saad, Shreya Motkur, Jason Law, Sai Sushrutha Vemula, James Hosner, Ling Wang, Daniel Isaac · 2026
Read 31 Racial Demographic Reporting in Clinical Trials Informing NCCN Kidney Cancer Guidelines by Suhail Sapkota, Niket Shah, Asish Nepal, Maha Bayya, Nadeen Saad, Shreya Motkur, Jason Law, Sai Sushrutha Vemula, James Hosner, Ling Wang, Daniel Isaac (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13535423.txt.
Description
Suhail Sapkota and co-authors check in a 2026 study how well race is reported in kidney cancer trials. Care guides from a major cancer network rest on these trials, yet the groups hit hardest by the disease may not be in them. Black, Native American, and Alaska Native groups face a higher burden, the authors note.
The team screened 262 sources cited in the network's kidney cancer guide and kept 92 trials. Of those, just 39, or 42.4%, reported the race of the people in the trial. The review also tracked who took part, year, and place, and it compared US trials with those from abroad. The gaps raise doubts about how well the guide fits all patients.
Catalog record
| CREATOR | Suhail Sapkota, Niket Shah, Asish Nepal, Maha Bayya, Nadeen Saad, Shreya Motkur, Jason Law, Sai Sushrutha Vemula, James Hosner, Ling Wang, Daniel Isaac |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |